Living Donor Lung Transplantation for Pleuroparenchymal Fibroelastosis

被引：18

作者：

Hata, Atsushi

Nakajima, Takahiro

Yoshida, Shigetoshi

Kinoshita, Taku

Terada, Jiro

Tatsumi, Koichiro

Matsumiya, Goro

Date, Hiroshi

Yoshino, Ichiro

机构：

[1] Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chiba, Japan

[2] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan

[3] Chiba Univ, Grad Sch Med, Dept Cardiovasc Surg, Chiba, Japan

[4] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto, Japan

来源：

ANNALS OF THORACIC SURGERY | 2016年 / 101卷 / 05期

基金：

日本学术振兴会;

关键词：

D O I：

10.1016/j.athoracsur.2015.07.056

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report the first patient with pleuroparenchymal fibroelastosis (PPFE) to undergo living donor bilateral lobar lung transplantation. The patient was diagnosed with secondary PPFE as a late complication of chemotherapy that included high-dose cyclophosphamide for mature B-cell lymphocytic leukemia. Although the patient maintained complete remission, dry cough and back pain appeared 8 years after the chemotherapy. He had repeated bilateral pneumothoraces, and his respiratory condition gradually deteriorated because of progressive pleural thickening and parenchymal fibrosis. He underwent living-donor bilateral lobar lung transplantation with an inverse transplant on the left side. (C) 2016 by The Society of Thoracic Surgeons

引用

页码：1970 / 1972

页数：4

共 8 条

[1] LATE-ONSET PULMONARY FIBROSIS AND CHEST DEFORMITY IN 2 CHILDREN TREATED WITH CYCLOPHOSPHAMIDE [J].